Home
About
Company
Organization
History
Team
Honor
Culture
Concept
Responsibility
Memoir
Video
News
Company notice
Company news
Media coverage
Innovation
Quality
HSE
Product
Halobios
Preparation
Raw material
Chinese Medicine
Health Products
Medical instrument
Service
Contact
Network
Stock code
603811
CN
Stock code
603811
Home
News
Company news
Company news
2024,04,27
Joint drugs have seen steady growth in revenue for many years, and fish oil health products have emerged as a rising star. Securities Times
2024,04,27
Realize a net profit of 163 million yuan in 2023 and adhere to a high proportion of dividends to give back to investors
2024,04,21
Cheng Yi Pharmaceutical insists on annual dividends to benefit all investors
Cheng Yi
Company notice
Company news
Media coverage
2022,01,13
Guo Yunqiang works on-site at Cheng Yi Pharmaceutical
2021,12,10
Zhejiang Chengyi Pharmaceutical "Menniao" Preparation has obtained a drug registration certificate
2021,11,29
District Party Secretary Guo Yunqiang and his delegation visited Yan Yiyi
2021,11,12
Expert Zhao Bowen and others conducted research on Cheng Yi Pharmaceutical
2021,09,17
Wenzhou Mayor Yao Gao and his delegation came to the company for research
2021,09,08
Private enterprises in the Yangtze River Delta cluster together as the "Big Hongqiao"
2021,05,04
40 Entrepreneurs from Wenzhou Visited and Inspected Cheng Yi Pharmaceutical Industry
2021,04,15
The first season of the "14th Five Year Plan" has achieved a "good start"
2021,03,25
Charity Day Donation: Undertaking Social Responsibility and Showcasing Corporate Style
2021,03,15
Leading in the pharmaceutical industry. Stable performance growth over the years
2020,12,24
Cheng Yi Pharmaceutical Enters the Rank of Wenzhou's "Top 100 Comprehensive Enterprises"
2020,12,16
Marine biopharmaceuticals: Another good news
<
1
...
3
4
5
...
11
>
Contact Us
view more